Microba Life Sciences acquires UK microbiome testing leader Invivo for A$12.5 million
SYDNEY, AUSTRALIA: Microba Life Sciences Limited (ASX:MAP), a leading provider of microbiome testing services, has announced the acquisition of Invivo Clinical Limited (Invivo), a UK-based...